Loretta Loftus

1.5k total citations
46 papers, 821 citations indexed

About

Loretta Loftus is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Loretta Loftus has authored 46 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 17 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Loretta Loftus's work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (9 papers) and Advanced Breast Cancer Therapies (7 papers). Loretta Loftus is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (9 papers) and Advanced Breast Cancer Therapies (7 papers). Loretta Loftus collaborates with scholars based in United States. Loretta Loftus's co-authors include Wilfred Niels Arnold, Christine Laronga, Paul B. Jacobsen, John V. Kiluk, Paul G. Cuddy, Géza Ács, Bruce F. Barker, Nicole N. Esposito, Leigh Anne Faul and Charles C. Williams and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Loretta Loftus

42 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loretta Loftus United States 15 386 253 149 132 89 46 821
K. S. Gopinath India 15 389 1.0× 192 0.8× 185 1.2× 156 1.2× 151 1.7× 54 1.0k
César A. Rodríguez Spain 20 627 1.6× 372 1.5× 211 1.4× 79 0.6× 86 1.0× 73 1.4k
Josep Corominas Spain 22 629 1.6× 422 1.7× 239 1.6× 192 1.5× 90 1.0× 55 1.7k
Henrik Flyger Denmark 14 339 0.9× 172 0.7× 142 1.0× 103 0.8× 82 0.9× 22 730
Inger Højris Denmark 13 888 2.3× 512 2.0× 268 1.8× 90 0.7× 228 2.6× 20 1.4k
Kristin V. Reinertsen Norway 18 817 2.1× 131 0.5× 312 2.1× 68 0.5× 139 1.6× 48 1.3k
Miep A. van der Drift Netherlands 14 279 0.7× 144 0.6× 317 2.1× 145 1.1× 195 2.2× 22 909
Dejana Braithwaite United States 14 288 0.7× 121 0.5× 148 1.0× 23 0.2× 47 0.5× 63 741
Raymond Snyder Australia 11 869 2.3× 465 1.8× 301 2.0× 77 0.6× 77 0.9× 19 1.3k
Haide Qin China 16 173 0.4× 200 0.8× 137 0.9× 46 0.3× 205 2.3× 34 1.0k

Countries citing papers authored by Loretta Loftus

Since Specialization
Citations

This map shows the geographic impact of Loretta Loftus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loretta Loftus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loretta Loftus more than expected).

Fields of papers citing papers by Loretta Loftus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loretta Loftus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loretta Loftus. The network helps show where Loretta Loftus may publish in the future.

Co-authorship network of co-authors of Loretta Loftus

This figure shows the co-authorship network connecting the top 25 collaborators of Loretta Loftus. A scholar is included among the top collaborators of Loretta Loftus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loretta Loftus. Loretta Loftus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Kamran A., Youngchul Kim, John A. Arrington, et al.. (2025). Phase II trial of brain MRI surveillance in stage IV breast cancer. Neuro-Oncology. 27(6). 1550–1558. 1 indexed citations
2.
Ahmed, Kamran A., Youngchul Kim, Daniel Oliver, et al.. (2024). Phase I/II study of stereotactic radiation and sacituzumab govitecan with zimberelimab in the management of metastatic triple negative breast cancer with brain metastases.. Journal of Clinical Oncology. 42(16_suppl). TPS1140–TPS1140.
3.
4.
Boulware, David, et al.. (2022). A Real-World Data Retrospective Cohort Study of Low Estrogen Receptor-Positive Early Breast Cancer: Natural History and Treatment Outcomes. Breast Cancer Targets and Therapy. Volume 14. 199–210. 3 indexed citations
5.
Sun, James, Junjie Ma, Weihong Sun, et al.. (2021). Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia. Cancer Medicine. 10(21). 7665–7672. 13 indexed citations
6.
Basu, Amrita, Ganesan Ramamoorthi, Krithika N. Kodumudi, et al.. (2021). Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination. Frontiers in Immunology. 12. 786286–786286. 8 indexed citations
7.
Sun, James, Brittany Mathias, Weihong Sun, et al.. (2020). Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?. Annals of Surgical Oncology. 28(1). 320–329. 19 indexed citations
8.
Loftus, Loretta, Gerald H. Sokol, & Christine Laronga. (2017). Breast Cancer Survivorship: Patient Characteristics and Plans for High-Quality Care. Southern Medical Journal. 110(10). 673–677. 3 indexed citations
9.
Abbott, Andrea M., Loretta Loftus, Weihong Sun, et al.. (2015). Intraoperative radiotherapy for early breast cancer and age: clinical characteristics and outcomes. The American Journal of Surgery. 210(4). 624–628. 10 indexed citations
10.
Loftus, Loretta, et al.. (2014). Race of the Clock: Reducing Delay to Curative Breast Cancer Surgery. Journal of the National Comprehensive Cancer Network. 12(suppl 1). S–13. 6 indexed citations
11.
Ács, Géza, John V. Kiluk, Loretta Loftus, & Christine Laronga. (2013). Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas. Modern Pathology. 26(11). 1451–1460. 24 indexed citations
12.
13.
Vandergrift, Jonathan L., Joyce C. Niland, Richard L. Theriault, et al.. (2012). Time to Adjuvant Chemotherapy for Breast Cancer in National Comprehensive Cancer Network Institutions. JNCI Journal of the National Cancer Institute. 105(2). 104–112. 93 indexed citations
14.
Ács, Géza, Nicole N. Esposito, John V. Kiluk, Loretta Loftus, & Christine Laronga. (2011). A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas. Modern Pathology. 25(4). 556–566. 53 indexed citations
15.
Burris, Jessica L., Paul B. Jacobsen, Loretta Loftus, & Michael A. Andrykowski. (2011). Breast cancer recurrence risk reduction beliefs in breast cancer survivors: prevalence and relation to behavior. Psycho-Oncology. 21(4). 427–435. 22 indexed citations
16.
Lee, Marie Catherine, et al.. (2011). Factors Affecting Lymph Node Yield in Patients Undergoing Axillary Node Dissection for Primary Breast Cancer: A Single-Institution Review. Annals of Surgical Oncology. 19(6). 1818–1824. 11 indexed citations
17.
18.
Loftus, Loretta, et al.. (1997). Evaluation of Student Performance in Combined Baccalaureate-MD Degree Programs. Teaching and Learning in Medicine. 9(4). 248–253. 8 indexed citations
19.
Loftus, Loretta & Wilfred Niels Arnold. (1994). Acquired hemophilia in a patient with myeloma.. PubMed. 160(2). 173–6. 9 indexed citations
20.
Arnold, Wilfred Niels & Loretta Loftus. (1991). Xanthopsia and van Gogh's yellow palette. Eye. 5(5). 503–510. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. S. Gopinath Breakdown of academic impact, for papers by César A. Rodríguez Breakdown of academic impact, for papers by Josep Corominas Breakdown of academic impact, for papers by Henrik Flyger Breakdown of academic impact, for papers by Inger Højris Breakdown of academic impact, for papers by Kristin V. Reinertsen Breakdown of academic impact, for papers by Miep A. van der Drift Breakdown of academic impact, for papers by Dejana Braithwaite Breakdown of academic impact, for papers by Raymond Snyder Breakdown of academic impact, for papers by Haide Qin
Rankless by CCL
2026